A Study of Allogeneic Human UC-MSC and Liberation Therapy (When Associated With CCSVI) in Patients With RRMS
Phase 1
Terminated
- Conditions
- Multiple Sclerosis, Relapsing-Remitting
- Interventions
- Biological: Allogeneic Human Umbilical Cord Tissue-Derived Mesenchymal Stem CellsOther: Liberation therapy
- First Posted Date
- 2015-04-16
- Last Posted Date
- 2015-11-04
- Lead Sponsor
- Genesis Limited
- Target Recruit Count
- 69
- Registration Number
- NCT02418325
- Locations
- 🇹🇹
Genesis Institute of Cellular Medicine, Genesis (Trinidad and Tobago) Private Limited, San Fernando, Trinidad, Trinidad and Tobago
© Copyright 2025. All Rights Reserved by MedPath